Summary
Elevance Health, Inc. (then operating as WellPoint, Inc.) filed an 8-K on March 15, 2007, to disclose its upcoming meetings with securities analysts and investors. The primary purpose of these meetings, scheduled between March 16 and March 31, 2007, was to reaffirm the company's confidence in meeting previously issued earnings expectations. These expectations were originally communicated on January 24, 2007, through a press release and conference call, with a copy of that release furnished as an exhibit to a prior 8-K filing. This disclosure signals management's intent to provide a consistent outlook to the investment community and manage expectations regarding the company's financial performance during that period.
Key Highlights
- 1Company confirmed upcoming meetings with securities analysts and investors from March 16 to March 31, 2007.
- 2Purpose of meetings was to confirm ability to meet previously stated earnings expectations.
- 3Earnings expectations were initially provided on January 24, 2007, via a press release and conference call.
- 4The press release from January 24, 2007, was attached as an exhibit to a prior 8-K filing.
- 5This filing is a Regulation FD disclosure, aiming to ensure broad dissemination of information.
- 6Information furnished in this 8-K is not considered 'filed' for Section 18 purposes and will not be incorporated into future filings under the Securities Act.